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ABSTRACT
Small, hydrophobic proteins whose synthesis is
repressed by small RNAs (sRNAs), denoted type I
toxin–antitoxin modules, were first discovered on
plasmids where they regulate plasmid stability,
but were subsequently found on a few bacterial
chromosomes. We used exhaustive PSI-BLAST
and TBLASTN searches across 774 bacterial
genomes to identify homologs of known type I
toxins. These searches substantially expanded the
collection of predicted type I toxins, revealed
homology of the Ldr and Fst toxins, and suggested
that type I toxin–antitoxin loci are not spread by hor-
izontal gene transfer. To discover novel type I toxin–
antitoxin systems, we developed a set of search
parameters based on characteristics of known loci
including the presence of tandem repeats and
clusters of charged and bulky amino acids at the
C-termini of short proteins containing predicted
transmembrane regions. We detected sRNAs for
three predicted toxins from enterohemorrhagic
Escherichia coli and Bacillus subtilis, and showed
that two of the respective proteins indeed are
toxic when overexpressed. We also demonstrated
that the local free-energy minima of RNA folding
can be used to detect the positions of the sRNA
genes. Our results suggest that type I toxin–anti-
toxin modules are much more widely distributed
among bacteria than previously appreciated.
INTRODUCTION
Plasmid maintenance in many bacteria is attributed to
the presence of toxin–antitoxin loci on the plasmids.
These loci consist of two genes: one encodes a stable
toxic protein, and the second an unstable antitoxin.
If the plasmid is lost from the cell upon division, the
unstable antitoxin is degraded, and the stable toxin
is able to kill the cell. This phenomena, referred to as
‘post-segregational killing’ or ‘plasmid addiction’ has
been described for plasmids in both Gram negative and
Gram positive bacteria. The toxin–antitoxin loci are
categorized into two broad classes based on the type of
antitoxin: the antitoxin of type I systems is a small RNA
(sRNA) which base pairs with the toxin mRNA to prevent
protein synthesis, whereas the antitoxin of the type II
systems is a protein that binds to and inhibits the toxin
protein. Generally, type I toxins are small (under 60 amino
acids in length), highly hydrophobic proteins, while type II
toxins are slightly larger ( 100 amino acids) and less
hydrophobic. The best-studied type I toxin–antitoxin
systems include the hok-sok locus of plasmid R1,
and the par locus of plasmid pAD1 of Enterococcus
faecalis (1,2).
Although the toxin–antitoxin loci were initially
described on plasmids, recent studies have shown that
many of these gene pairs are also present on bacterial chro-
mosomes. The type II toxin–antitoxin systems, in which
the antitoxin is a protein, have been documented in diverse
bacteria with many genomes carrying dozens of distinct
toxin–antitoxin pairs (3). The type II toxins have been
shown to degrade RNA or inhibit cellular enzymes such
as DNA gyrase (4,5). The physiological role(s) of the type
II systems remains a subject of debate; proposed func-
tions include stress survival, protection of the bacteria
against foreign DNA, and stabilization of chromosomal
regions (6,7).
Several studies have shown that type I toxin–antitoxin
systems, in which the antitoxin is an sRNA, are also
present on some bacterial chromosomes. The hok-sok
locus from plasmid R1 is encoded in the genomes of
several enteric bacteria (8,9). In some strains, the
sequences of these loci have degenerated and appear to
be non-functional whereas in other cases, the systems
are intact. Similarly, the par locus from plasmid pAD1 is
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casei and a Staphylococcus saprophyticus strain (10).
Additional type I toxin–antitoxin loci were found
serendipitously on bacterial chromosomes (1). These
include the ldr-rdl, ibs-sib, tisB-istR-1 and shoB-ohsC loci
of Escherichia coli and the txpA-ratA locus of Bacillus
subtilis. Interestingly, for these loci, there was no
reported homology to known plasmid sequences.
However, as for the plasmid-encoded systems, over-
production of the corresponding protein leads to cell
death, and this toxicity is repressed by an antisense
sRNA regulator. The exact biochemical activities of the
small, hydrophobic toxin proteins are not known,
although similarity to phage holin proteins has been
noted, and overexpression of the proteins is associated
with membrane depolarization and increased membrane
permeability (1). As for the chromosomally-encoded
type II toxin–antitoxin loci, the physiological function(s)
of the chromosomally-encoded type I toxin–antitoxin
systems remains unclear.
As mentioned above, type II toxin–antitoxin loci
are broadly distributed among diverse bacteria. We
hypothesized that type I systems are also widespread. To
test this, we sought to identify homologs of the known
type I toxins. Our computational approach identiﬁed
many more putative toxins than have been previously
reported. We experimentally validated a homolog of the
par locus encoded in the chromosome of Streptococcus
pneumoniae, the ﬁrst report of a type I toxin–antitoxin
system in this pathogen.
In addition to documenting the distribution of
known type I systems in bacteria, we sought to identify
new type I loci. Given the hydrophobicity and short length
of type I toxins, and the diﬃculties in predicting sRNAs
computationally, we developed search parameters based
upon the characteristics of the known type I toxin–anti-
toxin systems. For example, given that the ibs-sib and
ldr-rdl loci of E. coli are duplicated in the same intergenic
region, we hypothesized that a short open reading frame
(ORF) encoding a protein with a putative transmembrane
domain and repeated in tandem could be a component of
a type I toxin–antitoxin system. We also searched for
amino acid sequences containing speciﬁc features derived
from the analysis of known toxins, such as polar
C-terminal residues. Finally, because the known antitoxin
sRNAs form complex secondary structures, we developed
a computational approach based upon the RNA folding
energy proﬁle of a putative type I locus to identify the
location of the antisense sRNAs. Through these multiple
approaches, we identiﬁed three new type I toxin–antitoxin
loci which were experimentally validated. Our searches
greatly expand the number of type I toxin–antitoxin
systems known to be encoded in bacterial genomes.
MATERIALS AND METHODS
Computational approaches
Sequence data. All analyzed sequences were from the
non-redundant protein sequence database at the NCBI.
For the analysis of completed genomes, the RefSeq v.30
database was used for obtaining genome sequences and
annotation (ftp://ftp.ncbi.nih.gov/genomes/Bacteria/).
Exhaustive PSI-BLAST and TBLASTN searches.
Methodological problems associated with a similarity
search for short proteins are well-recognized. We tried
diﬀerent sets of parameters to improve the recognition
of type I toxins by PSI-BLAST (Supplementary Table
S1). The best results were obtained with the following
set of parameters: matrix=PAM70; word size=2, gap
cost=existence 9, extension 2; PSI-BLAST inclusion
threshold=1; expect threshold=100; no low complexity
ﬁltering; no composition based statistics (11). Searches at
the NCBI server were performed for each protein family
of the known type I toxins. After each run, all hits were
clustered (with a sequence identity cutoﬀ of 95%), and one
representative from each cluster was used as a query for a
new PSI-BLAST search until no new sequences were
detected. Hits below the PSI-BLAST inclusion threshold
were carefully inspected after each iteration, and if some
of these hits were to a protein from a species closely
related to those already detected and had other character-
istic features of type I toxins (a predicted membrane
protein under 70 amino acids in length), the respective
sequences were manually included into the proﬁle for the
next search iteration. We denote this procedure exhaustive
PSI-BLAST (Figure 1A). A similar approach was carried
out with the TBLASTN program for those type I toxins
that are often missed by ORF prediction programs
(Figure 1B). The only diﬀerence is that TBLASTN
cannot be used in an iterative mode, so the coverage of
the respective families could be improved only by using
multiple queries. Accordingly, all non-identical sequences
from each toxin family were used as queries for
TBLASTN searches.
Search for tandem repeats. Previous studies have shown
that type I toxin–antitoxin loci have a tendency to be
tandemly duplicated in the genomes of some bacteria
(12,13). Many of these regions did not have annotated
ORFs corresponding to the toxin. A pipeline of in-house
Perl scripts was developed to detect tandem genes
encoding proteins with characteristics similar to those of
type I toxins, including genes missed by ORF prediction
programs. The procedure includes the following steps
(Figure 1C). First, the intergenic regions were extended
by 30nt into each of the two adjacent coding regions to
allow for the possibility that the start (more common) or
stop codons of the adjacent ORFs were annotated
erroneously. Second, each intergenic region was translated
in all 6 possible frames; predicted proteins longer than
70 amino acids and shorter than 16 amino acids were
excluded. Third, the remaining proteins were searched
for potential transmembrane helices using two
approaches. For proteins longer than 50 amino acids,
the TMHMM prediction method was employed (14).
Since membrane protein prediction programs often
perform poorly for short proteins, we had to apply a
simpler approach to detect potential membrane proteins
shorter than 50 amino acids. For such proteins we
required at least one stretch of 15 amino acids with a
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Figure 1. Computational approaches used to identify and predict type I toxins. (A) Exhaustive PSI-BLAST to identify homologs of known toxins
not among previously annotated protein sequences. (B) Exhaustive TBLASTN search to identify homologs of known type I toxins not among
previous annotated ORFs. (C) Tandem repeat search to identify new type I toxins encoded in the same intergenic region. (D) Search for new type I
toxins based upon characteristics of known toxins.
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A) as an approximation for a transmembrane region. All
predicted proteins that did not have a membrane region
predicted by either approach were discarded. Fourth, to
exclude protein fragments or pseudogenes, each remaining
predicted protein was searched against the corresponding
proteome using BLASTP. Predicted proteins with a highly
signiﬁcant match to previously annotated, longer proteins
(e-value <10 and no more than two gaps) were excluded.
The remaining proteins were also searched against the
genomic DNA sequence by the TBLASTN program to
ﬁnd evidence that they might be located in a region
which is likely to be non-coding. Those that matched a
translated fragment containing one or more stop codons
were considered as non-coding and discarded. Finally, to
detect repeated sequences, the remaining predicted
proteins in each intergenic region were grouped using
BLASTCLUST (50% amino acid identity; length
coverage 0.7 for at least one ORF). Since the small type
I toxins generally do not have a variable length and
internal gaps within a family, we required that no more
than two internal and no more than one C-terminal gaps
occur in the alignment of the proteins within a cluster.
Identiﬁcation of characteristic features of type I toxins. We
combined previously observed features of type I toxins
with the new features identiﬁed in this work (for the set
of type I toxins identiﬁed by PSI-BLAST and TBLASTN)
in order to detect putative new toxin loci (Figure 1D,
Supplementary Table S2). First, we took into account
the observation that type I toxins are small (generally  
70 amino acids in length) and secondly are membrane
proteins. Third, type I toxin genes are separated from
their neighboring genes by relatively long intergenic
regions. We analyzed the up- and down-stream regions
of the type I toxin genes and calculated the mean value
for the up- and down-stream distances for all families
(Supplementary Table S2). Based on the results of this
analysis, we set the following thresholds for the distance
between the putative toxin and its ﬂanking genes: >400nt
between the toxin and the gene upstream, and >250nt
between the toxin and the gene downstream (Figure
1D). Finally, we noticed that many type I proteins have
clusters of charged or bulky amino acids at their
C-terminus. Therefore, in the selected genome set, we
computed the absolute frequencies (number of occur-
rences) of non-hydrophobic amino acids within the
10C-terminal amino acids for the combined set of all
type I toxins identiﬁed by PSI-BLAST and TBLASTN
in those genomes (Supplementary Table S2). We used
these absolute frequencies to calculate a score for the
10C-terminal amino acids for a protein. This was done
by assigning a corresponding value of absolute frequency
from the above estimate to each non-hydrophobic amino
acid and calculating the sum of all such values.
Multiple sequence alignment and phylogenetic analysis
methods. Multiple alignments of protein sequences were
constructed using the MUSCLE program (15).
Maximum likelihood (ML) phylogenetic trees were con-
structed from an alignment by using the MOLPHY
program (16) with the JTT substitution matrix to
perform local rearrangement of an original Fitch tree
(17). The MOLPHY program was also used to compute
RELL bootstrap values. Prediction of transmembrane
helices was performed using TMHMM program (14)
implemented in the web server (http://www.cbs.dtu
.dk/services/TMHMM-2.0/).
Prediction of RNA secondary structure. Sequences of pre-
dicted and experimentally detected antisense sRNAs,
random sequences from the same genomes and di-shuﬄed
sequences were computationally folded, and the free
energy of the most stable secondary structure was
calculated using Afold and Mfold, as described previously
(18,19). Energy minimization was performed by a dynamic
programming method that employs nearest neighbor
parameters to evaluate free energy and ﬁnds the secondary
structures with the minimum free energy by summing up
the contributions from stacking, loop length, and other
structural features, using improved thermodynamic
parameters (20–22). The sequence fold variant with the
lowest secondary-structure energy was used in our
analysis. The P-values for randomizations were calculated
using paired t-tests (18). Results were presented as the
free-energy proﬁles along the nucleotide sequences of
interest with window lengths corresponding to the
lengths of the antisense sRNAs. Starts and lengths of pre-
dicted antisense sRNAs were deﬁned as the local minima
of estimated free-energy proﬁles in the vicinity of pre-
dicted ORFs, taking into account the characteristic
features (location and length) of known type I toxin
families. The dinucleotide randomization procedure
randomly shuﬄed all dinucleotides, retaining nucleotide
composition of native RNAs (18,23).
Molecular approaches
Bacterial strains and plasmids. The strains and plasmids
utilized in this study are listed in Supplementary Table S3,
and the sequences of all oligonucleotides are given in
Supplementary Table S4.
Growth conditions. E. coli strains were routinely grown
in Luria–Burtani (LB) medium (10g tryptone, 5g yeast
extract and 10g NaCl per liter) or M9 minimal glucose
medium (1mM MgSO4, 0.1mM CaCl, 1mg/ml thiamine
and 0.2% glucose) at 37 C with shaking. Arabinose was
added as indicated to a ﬁnal concentration 0.2%. Bacillus
subtilis strains were grown in LB at 37 C with shaking.
IPTG was supplemented to a 1mM ﬁnal concentration as
indicated. Enterococcus faecalis OG1RF was grown in
BHI medium (Difco) at 37 C. Streptococcus pneumoniae
R6 was grown in BHI at 37 C in an atmosphere contain-
ing 5% (vol/vol) CO2/95% air. Antibiotics were added as
needed at the following concentrations: 25mg/ml
chloramphenicol, 100mg/ml spectinomycin, 100mg/ml
ampicillin.
RNA extraction. For E. coli, total RNA was harvested
from cells grown in LB or M9 + 0.2% glucose media
harvested at OD600  0.4 and from overnight cultures
(OD600  5.0 in LB; OD600  2.2 in M9) by the method
3746 Nucleic Acids Research, 2010,Vol.38, No. 11of hot acid phenol as previously described (12). For B.
subtilis, S. pneumoniae and E. faecalis strains, RNA was
isolated as described (24) with some modiﬁcations. Brieﬂy,
12-ml aliquots of culture were harvested by centrifuga-
tion at 4 Ca tO D 600  0.3, 1.0, 1.5 for E. faecalis
and S. pneumoniae, and at OD600  0.3, 2.0, 3.5 for
B. subtilis ssp. subtilis str. 168 and B. subtilis PY79.
Pellets were resuspended in 600ml of Solution GP
(50mM Tris–HCl, 10mM EDTA, 1% SDS, 30mM
sodium acetate), and transferred to tubes containing 0.5g
sterile glass beads (average diameter  106mm; Sigma) and
650ml of acid phenol:chloroform. The mixture was bead
beated twice for 45s at 4 C. The samples were separated by
centrifugation, and the aqueous layer was transferred to
tubes containing 500ml of acid phenol: chloroform, and
incubated at 65 C for 10min. The supernatant was
extracted two more times with phenol: chloroform, and
once with chloroform. RNA was then ethanol precipitated,
and resuspended in RNase-free water.
Northern analysis. For all antitoxin sRNAs, total RNA
(10mg) was separated on a denaturing 8%
polyacrylamide–8M urea gel. For detection of the
z3289/z3290 mRNAs, total RNA (10mg) was separated
on a denaturing 6% polyacrylamide–8M urea gel. RNA
was then transferred to a Zeta-Probe Genomic GT
membrane (Bio-Rad). The membranes were incubated
with speciﬁc oligonucleotide probes labeled with
32Pb y
T4 polynucleotide kinase and washed as previously
described (25).
Primer extension analysis. Total RNA (5mg) was used for
primer extension analysis as previously described, and
cDNA products were separated on a denaturing 8%
polyacrylamide–8M urea gel (25). Gene speciﬁc primers
are found in Supplementary Table S4.
Overproduction of toxic proteins. For the toxicity studies
in E. coli MG1655, potential toxins were cloned behind
the PBAD promoter of the pAZ3 vector (26). As the ends of
the potential toxin mRNA were unknown, a region con-
taining  50nt upstream of the predicted ribosome binding
site and 100nt downstream of the stop codon was
ampliﬁed from genomic DNA, digested with EcoRI and
HindIII, and cloned into the corresponding sites of pAZ3.
For yhzE-2, the ampliﬁed fragment and pAZ3 were
digested with EcoRI and XbaI.
To overproduce the toxins in B. subtilis PY79, the same
regions were ampliﬁed from genomic DNA, digested with
NheI and SphI, and cloned behind the Plac promoter of
pDR111 (27). The resulting plasmids were then used for
recombination into the amyE locus of B. subtilis PY79.
Integration was conﬁrmed by PCR and sequencing.
RESULTS
Identiﬁcation of additional members of
previously-characterized type I toxin–antitoxin families
Several studies have used sequence similarity searches,
and in particular TBLASTN with default parameters,
to identify chromosomally-encoded type I toxins (9,10).
However, given the short lengths of these proteins and
the strict parameters of such similarity searches, we sus-
pected that a substantial fraction of homologs might
have been missed in these studies. Thus, we performed a
comprehensive analysis using customized, exhaustive
PSI-BLAST and TBLASTN searches for 774 complete
bacterial genomes (Figure 1A and B, and ‘Materials and
Methods’ section). The results, presented in full in
Supplementary Tables S5 and S6, and as a condensed
list in Table 1 (for multiple alignments, see Supplementary
Figure S1), substantially expand the number of detected
type I toxin homologs, especially when compared with
results that would be obtained if default BLAST parame-
ters were used (Supplementary Table S1).
Some families, such as the Hok (also denoted Gef),
TxpA, Ldr and Fst families, were well represented in
protein databases; the best-annotated group is the Hok
family in which 72% are correctly named proteins. By
contrast, others, such as the Ibs, TisB and ShoB
families, were often missed by ORF-calling programs.
The majority of the putative type I toxins that we
identiﬁed with this approach are currently annotated as
‘hypothetical proteins’ or are unannotated.
To date, type I toxin–antitoxin loci have been experi-
mentally characterized only in a few lineages of
Enteroproteobacteria (Enterobacteria and Vibrionales)
and Firmicutes (Bacillus and Enterococcus genus) (1,2).
Our searches failed to detect any homologs of the
known type I toxins outside these taxa; however, we
identiﬁed previously unnoticed representatives of these
families in many additional lineages of Enteropro-
teobacteria and Firmicutes (Supplementary Tables S5
and S6). For example, Fst-like sequences were detected
in several Listeriaceae, Staphylococcaceae and
Clostridiales species, and TxpA-like sequences were
detected in Lactobacillales, Staphylococcaceae and
Clostridiales species (Supplementary Table S5). The
number of type I toxin loci varies greatly between diﬀerent
species and strains. So far the largest number was
identiﬁed in E. coli O157:H7 str. Sakai. This genome
carries 26 toxin–antitoxin loci of six distinct families
including 14 Hok/Gef genes and seven Ibs genes. Taking
into account our previous estimates of the number of type
II toxin–antitoxin loci (3) (given in Supplementary Table
S6) on a genome-wide scale we can conclude that type I
toxin–antitoxin system are even more abundant in some
genomes.
This approach also allows for the discovery of
non-trivial links between families. Thus, using exhaustive
PSI-BLAST, we detected a previously unnoticed connec-
tion between the Ldr and Fst families. The multiple amino
acid sequence alignment shows considerable conservation
between the two families including an apparent super-
family signature, a highly conserved tryptophan after a
predicted transmembrane helix followed by a cluster of
charged amino acids (Supplementary Figure S1A). This
ﬁnding implies that the two families are probably homol-
ogous. The Ldr and Fst toxins are widely distributed
across both Firmicutes and Enterobacteria. Given that
representatives of these families are found in potential
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3748 Nucleic Acids Research, 2010,Vol.38, No. 11vectors for horizontal gene transfer, such as phages and
plasmids, we were interested in potential evidence of hor-
izontal gene transfer, and reconstructed a phylogenetic
tree of the Ldr/Fst sequences. Despite limitations in tree
construction because the sequences are so short, we were
surprised to ﬁnd that the topology of the tree matched the
taxonomy of the respective bacteria (Supplementary
Figure S2). There was no evidence of recent horizontal
gene transfer events between distantly related bacteria
for this family of type I toxins. Instead, we infer that
there was a duplication of the ancestral toxin–antitoxin
locus in the common ancestor of enterobacteria (LdrD-
and LdrB-group) and in at least two distinct clades in
Staphylococcaceae. These duplications were followed by
other lineage-speciﬁc duplication events and a few losses
in some species.
We also constructed a tree for the Ibs family, for which
duplications in several genomes of enterobacteria were
detected as well (Supplementary Figure S3). The analysis
of this tree revealed the same trends as those seen in
the Ldr/Fst tree. At least three copies of the ibs gene
could have been present in the common ancestor of
Enterobacteriaceae, and two in the Pasteurellaceae and
the Haemophilus clades each. Subsequent duplications
occurred independently in Haemophilus somnus and
Shigella boydii lineages. These observations suggest that
duplications of the type I toxin–antitoxin loci are rela-
tively stable in evolution, with the implication that either
these loci are prone to duplication and subject to relaxed
selection, as in the case of transposons, or that the dupli-
cations are functionally important, possibly for stress
resistance (28,29), and accordingly are maintained by
purifying selection.
Experimental validation of the predicted Fst homologs
in S. pneumoniae
Two Fst homologs (referred to herein as Fst-A and Fst-B),
predicted by the exhaustive PSI-BLAST searches, are
encoded in tandem in 27 out of the 29S. pneumoniae
genomic sequences deposited in the Microbial genome
database at NCBI. These genes were missed by ORF pre-
diction programs used for genome annotation in several
strains including S. pneumoniae R6 (Figure 2A). The
ORFs in S. pneumoniae R6 are ﬂanked by fcsR, which
encodes an annotated regulator of the fucose operon,
and adcA, an ABC-transporter. We selected one of these
ORFs, Fst-B (genomic coordinates 1965747–1965842),
to test whether an antisense sRNA is expressed from the
same locus and whether the product of the ORF is indeed
toxic.
If the S. pneumoniae protein is functionally analogous
to Fst, there should be a corresponding antisense sRNA
regulator. The Fst protein is the toxin component of the
par locus of the plasmid pAD1. The organization of the
par locus has been well-characterized, and the antisense
sRNA regulator (RNA II) overlaps the 30-end of the
mRNA encoding the toxic protein (10,30,31). Total
RNA was isolated from S. pneumoniae R6 and used for
northern analysis. A strong signal corresponding to an
RNA species of  65–75nt was detected using an
end-labeled oligonucleotide complementary to the 30 end
of fst-B (Figure 2B). This signal is in agreement with the
previously characterized size and location of the antisense
sRNA from pADI, as well as RNA II expressed from
copies of the par locus encoded in the chromosomes of
other bacteria (10).
To test the toxicity of the protein, fst-B from
S. pneumoniae R6 was cloned on a plasmid behind an
arabinose-inducible promoter (PBAD) and overproduced
in E. coli MG1655. As shown in Figure 2C, induction of
the protein halted cell growth, and there was a signiﬁcant
decrease in colony forming units over time, conﬁrming
that high levels of this protein are indeed toxic.
Finding new type I toxin–antitoxins: tandem repeats
Among the previously identiﬁed chromosomally encoded
type I toxin–antitoxin systems, the ibs-sib and ldr-rdl loci
are repeated multiple times in the same intergenic region
(12,13). Therefore we developed a computational proce-
dure to identify tandem repeats encoding potential type I
toxins in intergenic regions of bacterial genomes. We then
examined a selected set of sequenced genomes in order
to identify new type I toxin families (see Figure 1C, and
‘Materials and Methods’ section). The complete search
results for Proteobacteria and Firmicutes are given in
Supplementary Table S7.
This approach reproduced some ﬁndings obtained
in our exhaustive BLAST search, including the
S. pneumoniae Fst toxins described above. The search
also led to the identiﬁcation of a duplication of the
apparent Ibs homologs in the genome of Helicobacter
pylori that were missed by TBLASTN but recently were
identiﬁed experimentally (32). We were particularly inter-
ested in further analyzing E. coli and B. subtilis toxin–
antitoxin candidates predicted by this approach.
Experimental analysis of new candidate type I toxins
from E. coli strain O157:H7
One repeat family was observed between yehI and yehL in
the enterohemmoragic E. coli strain O157:H7 EDL933.
Two genes, z3289 and z3290, encoding proteins 29 amino
acids in length each, are encoded in tandem and share
extensive sequence similarity that extends beyond the
coding region (Figure 3A). The same loci are present in
most E. coli and Shigella strains, and in Escherichia
fergusonii ATCC 35469, either as tandem repeats or as
single genes (Supplementary Table S7), but are not found
in the laboratory strain E. coli MG1655. In fact, the length
of the entire yehI-yehL intergenic region in MG1655 is
0.3kb compared to 1.2kb in O157:H7 EDL933.
The antitoxin RNAs described to date are encoded
directly opposite the coding sequence of the toxin,
opposite the 50 untranslated region (50 UTR), or
opposite the 30 UTR of the toxin mRNA, or even diver-
gent to the toxin gene but with long stretches of
complementarity to the toxin mRNA (1). We were
unable to detect antisense sRNAs using oligonucleotide
probes corresponding to the coding sequence, 50 or 30
UTR of z3289 and z3290 (data not shown). To test for
the presence of an sRNA in the region around z3289 and
Nucleic Acids Research, 2010,Vol.38, No. 11 3749z3290, we carried out northern analysis using three
riboprobes, which together would span a 1kb segment
encompassing the two small ORFs. We observed a
strong band of  80nt with the probe that spanned the
intergenic region between the two genes (data not
shown). To further reﬁne the position of the putative
sRNA, we calculated the predicted free-energy proﬁle of
the yehI-yehL intergenic region (see below). This analysis
revealed two local minima of predicted free-energy,
corresponding to regions of complex secondary structure,
240–300nt upstream of z3289 and z3290. Upon further
examination of these regions, we identiﬁed potential
terminators and promoter sequences (Supplementary
Figure 4A). Using oligonucleotides complementary to
these predicted sRNAs, we detected two transcripts of
 85nt in length each. Interestingly, these transcripts
were abundant during the exponential phase in both rich
and minimal media, but decreased during stationary phase
(Figure 3B).
As these sRNA genes were encoded divergent from the
toxin genes, we were interested in whether they had the
potential to base pair with the toxin mRNAs. There is
perfect complementarity between the sRNA (sRNA-1)
encoded divergent to z3289 and the sequence 72–92nt
upstream of the start codon of the toxin (Figure 3A).
Similar complementarity is also observed between z3290
Figure 2. (A) Multiple alignment of selected representatives of the Ldr/Fst family. Proteins studied in this work are denoted by asterisk, experi-
mentally characterized type I toxins are shown in bold; the predicted transmembrane region is shaded; conserved small amino acids are colored blue;
the conserved tryptophan is colored magenta; charged amino acids (RKDE) are colored red. The consensus was built using CONSENSUS program
(http://coot.embl.de/Alignment//consensus.html) for a larger set of Ldr/Fst proteins (see Supplementary Figure S1A). The sequences are denoted by
both the abbreviated species name and the GI number or the coordinates in the corresponding genome in parentheses. Species abbreviations: SP,
Streptococcus pneumoniae R6; CB, Clostridium bolteae; EC, Escherichia coli K-12 substr. MG1655; SB, Shigella boydii CDC 3083-94; SE, Salmonella
enterica arizonae z4z23; ECO, Escherichia coli O127:H6 str. E2348/69; SA, Staphylococcus aureus ssp. aureus Mu50; LG, Lactobacillus gasseri MV-22;
EF, Enterococcus faecalis plasmid pAD1. (B) Northern blot showing expression of an sRNA antisense to S. pneumoniae fst-B-homolog. Total RNA
(10mg) isolated from S. pneumoniae R6 cells grown to OD600  0.3 (E), OD600  1.0 (L) and OD600  1.5 (S) in BHI medium was loaded in each lane.
(C) Overproduction of the S. pneumoniae Fst-B homolog in E. coli. MG1655 harboring pAZ3-fst-B was grown in LB medium to OD600  0.3. The
culture was split (indicated by the arrow); half was left untreated (blue) while arabinose (0.2% ﬁnal concentration) was added to the other half (red).
Cell dilutions were plated 0 (T0) and 60 (T60)min following arabinose induction.
3750 Nucleic Acids Research, 2010,Vol.38, No. 11and the sRNA (sRNA-2) encoded divergent from this
gene (Figure 3A). We carried out primer extension
analysis to map the transcription start sites of the z3289
and z3290 mRNAs and the newly discovered sRNAs
(Supplementary Figure S4). The results indicate that
both toxin mRNAs contain long 50 UTRs (180nt),
similar to what has been reported with other toxins (1).
The gene orientations and base pairing potentials are very
reminiscent of the tisB-istR and shoB-ohsC toxin loci. In
these pairs, the sRNA is encoded divergent, and distant
from the toxin, but has the potential for extended base
pairing with the 50 UTR of the toxin mRNA.
The putative toxin genes were cloned with their native
ribosome binding sites, behind the PBAD promoter on a
multicopy plasmid to measure toxicity. Overproduction of
both small proteins (Figure 3C and data not shown) in the
laboratory strain E. coli MG1655 led to cell stasis and a
mild decrease in colony forming units, indicating that the
proteins are toxic at high levels.
Experimental analysis of new candidate type I
toxins from B. subtilis
A separate duplication was identiﬁed in B. subtilis ssp.
subtilis str. 168 genome. The duplicated gene encodes a
28 amino acid hydrophobic protein that is conserved
across multiple species of Firmicutes, but it is not
similar to any of the known type I toxins (Figure 4A
and Supplementary Figure S1C). One of these duplicated
Figure 3. (A) Genomic arrangement of EHEC Z3289 and Z3290. The ORFs are indicated by the black regions of the leftward arrows and the
regions of complementarity are indicated by the white boxes. The sequences capable of base pairing are shown below the gene arrangement. (B)
Multiple alignment of selected representatives of EHEC family. Most designations are the same as in the Figure 2A. The predicted transmembrane
regions is shaded (predicted for E. coli O157:H7 EDL933 proteins and extended for other sequences): small amino acids are colored blue; charged
amino acids (RKDE) are colored red. Species abbreviations (strains are also indicated for E. coli species): EC, E. coli; SB, Shigella boydii CDC
3083-94; SF, Shigella ﬂexneri 2a str. 2457T. (C) Expression of the antitoxin RNAs for Z3289 (sRNA-1) and Z3290 (sRNA-2). Total RNA (10mg)
isolated from E. coli O157:H7 EDL933 cells grown to OD600  0.4 (E) and OD600  5.0 (overnight, S) in LB medium and from cells grown to OD600
 0.4 (E) and OD600  2.2 (overnight, S) in M9 media supplemented with 0.2% glucose was loaded in each lane. (D) Overproduction of Z3290 in
MG1655. MG1655 harboring pAZ3-z3290 was grown in LB medium to OD600  0.3. The culture was split (indicated by the arrow); half was left
untreated (blue) while arabinose (0.2% ﬁnal concentration) was added to the other half (red). Cell dilutions were plated 0 (T0) and 60 (T60)min
following arabinose induction.
Nucleic Acids Research, 2010,Vol.38, No. 11 3751genes has been annotated as yhzE; herein, we will refer
to the annotated gene as yhzE-1 and the second copy in
the same intergenic region as yhzE-2. The genes encoding
proteins of this family are highly abundant in Firmicutes.
For instance, the Bacillus subtilis ssp. subtilis str. 168
genome contains eight genes for these proteins
(Supplementary Figure S1C and Figure 4A). Analysis of
an alignment of this family reveals a distinct feature: both
the N- and C-termini are highly variable in length but are
rich in glycines and aromatic residues (Supplementary
Figure S1C). Genes encoding these proteins are tandemly
duplicated in the genomes of several other bacteria and
are also present in several phages and plasmids.
Combined with the sequence features of this proteins,
such a distribution makes them possible type I toxin
candidates.
To test whether this region has features of a type I
toxin–antitoxin locus, we isolated RNA from B. subtilis
PY79 and carried out northern blot analysis. As the
B. subtilis ratA antitoxin RNA base pairs at the 30-end
of the toxin mRNA, we used an oligonucleotide probe
that overlaps the 30-end of the yhzE-2 ORF. A strong
signal, of  110–120nt in length was detected throughout
growth in rich media using this probe (Figure 4B).
Figure 4. (A) Multiple alignment of selected representatives of YhzE family. Most designations are the same as in the Figure 2A. The consensus was
built using CONSENSUS program for a larger set of YhzE family proteins (see Supplementary Figure S1C). The predicted transmembrane regions is
shaded (predicted for B. subtilis YhzE protein and extended for other sequences); small amino acids are colored blue; aromatic residues are colored
magenta. Species abbreviations: Bs, B. subtilis str. 168; Bph, Bacillus phage SPBc2; Gsp, Geobacillus sp. G11MC16; BH, B. halodurans C-125; BA, B.
anthracis str. Ames; Psp, Paenibacillus sp. JDR-2; BP, B. pumilus SAFR-032. (B) Expression of an sRNA antisense to yhzE-2. Total RNA (10mg)
isolated from B. subtilis PY79 cells grown to OD600  0.3 (E), OD600  2.0 (L) and OD600  3.5 (S) in LB medium was loaded in each lane. (C)
Overproduction of YhzE-2 and TxpA in B. subtilis PY79. YhzE-2 (graph on the left) or TxpA (right) under the control of the Plac promoter was
integrated into the amyE locus of PY79. The cultures were grown in LB medium to OD600  0.3. The cultures were split; (indicated by the arrow);
half was left untreated (blue) while IPTG (1mM ﬁnal concentration) was added to the other half (red).
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PBAD plasmid in E. coli MG1655 but observed no eﬀects
on growth (data not shown). Given that the protein is
native to B. subtilis and not E. coli, we next measured its
toxicity in B. subtilis. The yhzE-2 gene was cloned behind
the Plac promoter of the plasmid pDR111, and the con-
struct was integrated into the amyE gene of B. subtilis
PY79 (27). As a control, we similarly examined the
toxicity of TxpA, a known type I toxin found in B.
subtilis (33). TxpA was highly toxic to B. subtilis
whereas there were no obvious growth defects upon over-
production of YhzE-2 (Figure 4C). The lack of YhzE-2
mediated toxicity could be due to insuﬃcient levels of
protein production, possibly because of repression by
endogenous antisense sRNAs expressed from the
multiple paralogous copies of the locus. Alternatively,
the protein may not function as a toxin, even at high
levels.
Finding new type I toxin–antitoxins: characteristic
protein features
In addition to being encoded in tandem repeats, there are
other characteristics shared by many type I protein toxins.
The described type I toxins are under 70 amino acids in
length, contain a transmembrane region and a small
C-terminal region rich in polar or aromatic residues. The
toxin–antitoxin loci also are often encoded distant from
their ﬂanking genes. We combined these observations into
a set of search parameters (see ‘Materials and Methods’
section) taking into account data obtained by the analysis
of all known and new toxins described here (Figure 1D
and Supplementary Table S2). Brieﬂy, we identiﬁed all
proteins under 70 amino acids in length that were pre-
dicted to contain at least one transmembrane region. We
then selected those ORFs that were separated by at least
400nt from the upstream ﬂanking gene and by at least
250nt from the downstream gene. From this set of
proteins, we selected those that contained a C-terminus
rich in polar or aromatic residues. Results for the
selected genomes are presented in Supplementary Table
S8. Using these parameters, we identiﬁed, among other
putative novel type I toxins, the 27 amino-acid protein
BH0344 from Bacillus halodurans C-125, which has
homologs in several L. monocytogenes strains and in
E. faecalis V583 (protein EF3263), as well as YonT
encoded in the B. subtilis ssp. subtilis str. 168 genome. The
EF3263 and YonT proteins were chosen for further analysis.
Experimental validation of a candidate type I toxin in
E. faecalis V583
The use of exhaustive PSI-BLAST and TBLASTN
searches with the E. faecalis EF3263 protein as a
starting query led us to link this group of sequences with
the TxpA family (Supplementary Figure S1D, Figure 5A),
a connection we did not make with our preceding analysis.
This ﬁnding demonstrates that BLAST searches are highly
sensitive to query sequences and database content (which
had changed since we obtained the ﬁrst results for the
TxpA family described above). Accordingly, it seems
likely that we are still underestimating the number
of type I toxin genes even for known families and that
the development of new, customized computational
approaches, some of which are presented here, can help
ﬁnd homologs not identiﬁed by standard BLAST
searches.
As EF3263 is distantly related to TxpA, we predicted
that the organization of the EF3263 toxin–antitoxin gene
pair would be similar to that of TxpA-RatA (33). We
isolated RNA from E. faecalis OG1RF (which contains
EF3263) grown in BHI. As shown in Figure 5B, a tran-
script of  110nt in length was detected using a probe that
would overlap the 30 UTR of the EF3263 transcript. This
RNA, although readily detected under all growth condi-
tions examined here, appeared to accumulate as the cells
entered stationary phase, suggesting an increase in either
its transcription or stability under these conditions.
Toxicity of this protein was tested by overproduction
in E. coli, as described above. Upon induction of the
small protein, cell growth stopped and a mild decrease
in colony forming units was observed (Figure 5C). These
results show that EF3263 is toxic upon overexpression and
support the hypothesis that EF3263 is a divergent member
of the TxpA toxin family. Interestingly, overproduction of
TxpA in E. coli had no eﬀects on growth [(33) and data
not shown], suggesting that, despite their relatedness,
there are diﬀerences in the levels of the small proteins
and/or the functions of TxpA and EF3263.
Experimental validation of a candidate type I toxin
in B. subtilis
An additional protein identiﬁed using the search parame-
ters derived from the characteristic features of type I
toxins was YonT encoded in the genome of B. subtilis
ssp. subtilis str. 168 (Figure 6A). Given that the yonT
gene resides within the SPb prophage of B. subtilis, it
appeared to be a plausible toxin candidate.
Since the yonT region is absent in B. subtilis PY79,
which has been cured of SPb, we examined whether
there is an sRNA encoded in the antisense strand of
yonT in B. subtilis ssp. subtilis str. 168 (34). Northern
analysis of RNA isolated from cells grown in rich media
revealed the presence of a transcript, just under 100nt in
length, encoded opposite the 30 end of yonT. Upon longer
exposures, a smaller,  80nt band also could be seen, and
this transcript accumulates as the culture exits log phase
and enters stationary phase (Figure 6B).
To examine the toxicity of YonT, the gene with its pre-
dicted ribosome binding site was cloned behind the PBAD
promoter as described above. Induction of YonT led to a
decrease in the growth rate of E. coli although this eﬀect
was milder than the eﬀects of the other toxins examined in
this study, with the exception of YhzE-2 (Figure 6C).
Computational prediction of regulatory antisense sRNAs
using thermodynamic parameters of RNA folding
The known type I antitoxin RNAs are predicted to
fold into complex secondary structures (1,2). Thus, we
analyzed RNA secondary structures and RNA folding
characteristics to determine whether it is possible to
predict the location of antisense sRNA genes. Using
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estimate the free energy for optimal and suboptimal sec-
ondary structures (see ‘Materials and Methods’ section),
we ﬁrst created free-energy proﬁles for the previously
characterized antitoxin RNA regions. We found that
the transcriptional starts for all known antitoxin
RNAs (IstR1, Sok, SibA, SibB, RdlD, RatA) are
located in the local minima of predicted free-energy
proﬁles (Supplementary Figure S5). Speciﬁcally, the dif-
ferences in the local minima and the average free-energy
levels in the thermodynamic proﬁles for known antitoxin
RNAs compared to those calculated for di-shuﬄed
sequences and random sequences of comparable lengths
from the same genome were statistically signiﬁcant
(P<0.001).
To validate this approach, we compared the distribu-
tion of free-energy values for predicted antitoxin RNA
regions for known type I loci identiﬁed using BLAST
(Supplementary Table S9) with those for random
sequences of comparable lengths taken from elsewhere in
the same genomes, and with randomly shuﬄed sequences
with the same dinucleotide content as the RNA antitoxin
sequences (‘Materials and Methods’ section). The starts
and lengths of the predicted antitoxin RNA were deﬁned
Figure 5. (A) Multiple alignment of selected representatives of the TxpA family. The consensus was built using CONSENSUS program for a larger
set of the TxpA family proteins (see Supplementary Figure S1D). Most designations are the same as in the Figure 2A. The predicted transmembrane
regions is shaded (predicted for Enterococcus faecalis V583 protein and extended for other sequences). Species abbreviations: Bs, B. subtilis sub.
subtilis str. 168; Sph, Staphylococcus phage 42E; EFH, E. faecalis HH22; LC, Lactobacillus casei ATCC 334; LCI, Leuconostoc citreum KM20; LC,
Lactobacillus casei ATCC 334; Gs, Geobacillus sp. G11MC16; EFO, E. faecalis OG1RF; BH, B. halodurans C-125; EFV, E. faecalis V583. (B)
Northern blot showing expression of an sRNA antisense to EF3263 in E. faecalis OG1RF. Total RNA (10mg) isolated from E. faecalis OG1RF cells
grown to OD600  0.3 (E), OD600  1.0 (L) and OD600  1.5 (S) in BHI medium was loaded in each lane. (C) Overproduction of EF3263 in E. coli.
MG1655 harboring pAZ3-ef3263 was grown in LB medium to OD600  0.3. The culture was split (indicated by the arrow); half was left untreated
(blue) while arabinose (0.2% ﬁnal concentration) was added to the other half (red). Cell dilutions were plated 0 (T0) and 60 (T60)min following
arabinose induction.
3754 Nucleic Acids Research, 2010,Vol.38, No. 11based on the characteristic features (location and length)
of known type I toxin families. Again the folding free
energies for the predicted antisense sRNAs were substan-
tially lower than those for the di-shuﬄed sequences
(P=9.2E 32; Supplementary Figure S6). Notably,
mRNA folding energies for the random sequences were
distributed diﬀerently, as compared to those of the anti-
toxin RNAs that contain numerous domains capable of
folding into highly stable secondary structures. The results
show that the predicted antisense sRNA regions generally
have a propensity to form more stable secondary struc-
tures and possess lower free-energy values that the
random genomic sets (P=2.62E 12; Supplementary
Figure S6).
Using this approach, we predicted the locations of the
genes encoding the antitoxin RNAs identiﬁed in E. coli
O157:H7, B. subtilis and E. faecalis, and experimentally
analyzed in this study (Figure 7). The predicted energy
minima coincided perfectly with the sequences of the
oligonucleotides used to detect the sRNAs by northern
analysis. The analysis was particularly helpful for z3289
and z3290 of E. coli O157:H7, where antisense sRNAs
were not detectable with oligonucleotide probes corre-
sponding to the coding sequence, 50 or 30 UTR of the
genes. For these toxins the locations of putative sRNA
genes were predicted based on the analysis of the
free-energy proﬁle of the yehI-yehL intergenic region.
This analysis revealed two local minima of free energy,
which corresponded to the regions of complex
secondary-structure upstream of z3289 and z3290
(Figure 7B) and were conﬁrmed experimentally to
express sRNAs.
Whenever possible, the lengths of sliding windows were
chosen on the basis of the characteristic location and
length of known type I toxins. For new type I toxin
families, we performed a more extensive analysis with
sliding windows of varying length. Some of the local
free-energy minima observed outside of predicted ORFs
corresponded to annotated transcription terminators or
unrelated short ORFs and were excluded from consider-
ation. Most of the remaining stable free-energy minima,
readily detectable with diﬀerent window lengths, were
Figure 6. (A) Amino acid sequence of yonT gene product of Bacillus subtilis ssp. subtilis str. 168 (Bs). Charged amino acids (EKR) are colored red
and the predicted transmembrane regions is shaded. (B) Expression of an sRNA antisense to yonT. Total RNA (10mg) isolated from B. subtilis ssp.
subtilis str. 168 cells grown to OD600  0.3 (E), OD600  2.0 (L) and OD600  3.5 (S) in LB medium was loaded in each lane. A smaller band of
 80nt can be seen upon overexposure as the cells enter the stationary phase of growth. (C) Overproduction of YonT in E. coli. MG1655 harboring
pAZ3-yonT was grown in LB medium to OD600  0.3. The culture was split (indicated by the arrow); half was left untreated (blue) while arabinose
(0.2% ﬁnal concentration) was added to the other half (red). Cell dilutions were plated 0 (T0) and 60 (T60) min following arabinose induction.
Nucleic Acids Research, 2010,Vol.38, No. 11 3755candidates for experimental evaluation. Our results
support the observations that the antitoxins are encoded
by highly structured RNAs, which justiﬁes the use of this
parameter to predict new type I loci.
DISCUSSION
Several recent studies have focused on the identiﬁcation
and characterization of the many type II toxin–antitoxin
gene pairs in which both the toxin and antitoxin are pro-
teins. These loci are broadly distributed across bacteria
and archaea, and the numbers of loci vary extensively
between species. In contrast, little is known about the dis-
tribution of type I toxin–antitoxin loci in which the anti-
toxin is an antisense sRNA. We thus set out to screen for
homologs of known type I toxin–antitoxin pairs as well as
to identify new loci.
Approaches to identify type I toxin–antitoxin systems
Prior to these studies, identiﬁcation of homologs of known
type I toxins relied solely upon TBLASTN and PSI-
BLAST searches carried out using default parameters.
These searches revealed few homologs (9,10), and conse-
quently suggested that the distribution of these toxins was
Figure 7. Prediction of antitoxin sRNAs using free-energy proﬁles for RNA local secondary structures. Free-energy proﬁles for RNA local second-
ary structures along nucleotide sequences in experimentally tested RNA antitoxin systems in S. pneumoniae (A), E. coli (B), B. subtilis (C and E) and
E. faecalis (D). The lengths of the sliding window used for free-energy estimations (70 and 100nt) corresponded to common lengths of the previously
described sRNA antitoxins. Blue arrows show location of predicted ORFs. Red arrows show the positions of the oligonucleotides used to detect the
antisense sRNAs. Other local free-energy minima correspond to annotated terminators or unrelated short ORFs. x-axis: nucleotide positions; y-axis:
free energy of RNA folding.
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BLAST and TBLASTN searches, we predicted numerous
type I toxin–antitoxin loci in a wide range of bacteria
including homologs of the Fst toxins in S. pneumoniae,
which we experimentally validated. The combined results
from our searches greatly increased the number of known
toxins across many diﬀerent bacterial lineages (see
Supplementary Tables S1, S5 and S6). The majority of
the putative type I toxins that we identiﬁed with this
approach are currently annotated as ‘hypothetical
proteins’ or are not represented in protein databases at
all (missed by gene prediction methods). For example,
for the TxpA family, previously represented by the
single, originally identiﬁed type I toxin from B. subtilis
(33), we describe 118 representatives, of which only eight
were annotated as holin-like toxins.
The development of computational approaches to
identify novel type I toxin–antitoxin systems is challenging
due to the short, hydrophobic character of the toxin
proteins and the diﬃculty in predicting the antitoxin
sRNAs. By examining common features of known
toxins, we were able to establish a list of potential
features to use in searches for new families. Here we
described two computational approaches that led to dis-
covery of new type I toxin families. One nucleotide-based
approach identiﬁed tandemly repeated ORFs encoding
potential type I toxins in intergenic regions. The second
approach is based on the characteristics of known protein
sequences of type I toxins and was aimed at searching the
protein content of sequenced genomes. Both approaches
identiﬁed candidates that could be further analyzed
in silico and in vivo to test our predictions. We experimen-
tally examined three new putative toxin–antitoxin loci: the
Z3289/Z3290 family of EHEC and the YhzE and YonT
proteins of B. subtilis. All three loci were conﬁrmed to
have associated sRNAs and the Z3289, Z3290 and
YonT proteins were found to be toxic or partially toxic
at high levels.
We additionally found that the results could be reﬁned
by applying RNA folding predictions to the potential type
I loci. The characterized antisense sRNA antitoxins have
extensive secondary structures and are located in regions
that have very low predicted free-energies. By incorporat-
ing this observation, we were able to predict the location
of the type I antitoxin RNA genes. This was especially
useful in locating the sRNA regulators of the EHEC
toxins. Given that these sRNAs are not encoded directly
opposite the toxin genes, they would have been missed in
our searches. Overall, the regions of predicted low
free-energy corresponded well to the chromosomal
location of the antitoxins (Figure 7).
The computational approaches described here certainly
require further improvement. As a case in point, our
exhaustive PSI-BLAST search failed to identify the diver-
gent TxpA toxin in E. faecalis. Thus, even this approach
underestimates the number of such loci for known
families. In addition, our computational approaches
based upon toxin characteristics produced a considerable
number of apparent false positives. At present, there is no
single, universal criterion to identify false-positives among
the predictions. However, case-by-case analysis for
features such as the presence of a conserved ribosome
binding site, and start and stop codons allowed us to
dismiss a considerable fraction of detected ORFs as incon-
sistent with a type I toxin function (see Supplementary
Table S7). The novel type I toxin–antitoxin gene pairs
reported in this work should be helpful in the further
reﬁnement of the computational parameters and
methods described here.
It is also expected that new pairs of type I toxin–anti-
toxins will be identiﬁed in the transcriptomes of the many
bacteria that are being studied by whole genome expres-
sion analysis with tiling arrays or deep sequencing.
Indeed, homologs of the Ibs genes were detected by deep
sequencing of H. pylori (32). Similarly, a deep sequencing
study of Prochlorococcus, a marine cyanobacterium,
revealed two distinct loci encoding overlapping RNAs,
in which one gene in each pair is predicted to encode a
short protein (35) although further studies are required to
test the hypothesis that these are toxin–antitoxin pairs.
Overall, the computational part of this work pursued
two major goals. The ﬁrst was to achieve the maximum
coverage of the known type I toxin families and evaluate
the number of representatives of each family in sequenced
genomes. The second goal was to develop computational
approaches to predict new families of toxins that could
not be identiﬁed with sequence similarity searches. The
latter approach did not aim to ﬁnd all representatives of
putative new toxin families but rather to pinpoint a small
number of plausible candidates for further case-by-case
analysis using both computational and experimental tech-
niques. Once a new family is conﬁrmed as a true positive,
similarity search methods are the best way to identify
homologs of the respective proteins in genomes of interest.
Distribution and evolution of type I toxin–antitoxin
systems
The distribution of the previously characterized type I
toxin–antitoxin loci, as well as the new ones identiﬁed
here, can vary greatly. For example, homologs of ShoB
are found mainly in E. coli and Shigella, whereas Ldr/Fst
homologs are detected in multiple Firmicutes and enteric
bacteria (Supplementary Tables S5 and S6). Our analysis
of the evolution of type I toxins unexpectedly showed that,
unlike type II toxins, the type I toxin–antitoxin systems
are not prone to horizontal gene transfer, but instead have
evolved by lineage-speciﬁc duplication. The duplicated
copies are stable in evolution suggesting a possible func-
tional role of these loci in the respective organisms. Thus,
it appears that ShoB emerged later in evolution as it is not
present outside a group of closely related organisms.
In contrast, the genes of the Ldr/Fst family were
probably present in the ancestors of both Firmicutes and
enterobacteria taxa and retained by many lineages after
their divergence.
Interestingly, the sRNAs associated with the E. coli Ldr
proteins are encoded opposite the 50-ends of these genes,
while the sRNAs associated with the proteins that are more
Fst-like are encoded opposite the 30-ends of these genes.
This raises questions about the evolution of the toxin and
the antisense sRNA; when and how did the sRNA arise?
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tion of the ‘traditional’ type I toxin–antitoxin loci where
the sRNA is encoded opposite the toxin gene versus the
families such as ShoB-OhsC, TisB-IstR-1, Z3289-sRNA-1
and Z3290-sRNA-2 pairs, where the sRNA is encoded
divergent from the toxin gene, but possesses extensive
base pairing potential. Thus far these loci have only been
found in E. coli and closely related bacteria. However, pre-
dicting new families of this subset of type I toxin–antitoxin
modules is diﬃcult, and consequently it remains unknown
whether other bacteria possess toxin–antitoxin loci with
this divergent gene arrangement.
It is likely that still other permutations of type I toxin–
antitoxin loci as well as combinations of type I and II
toxin–antitoxin modules will be found. In E. coli, the
SymR antisense sRNA represses the synthesis of the
toxic SymE protein (26). Interestingly, although SymE
functions like a type II toxin, it actually resembles type
II antitoxins. A number of ‘orphan’ type II toxin genes
lacking the adjacent antitoxin gene have been found in
searches for type II loci (3); it is quite possible that the
synthesis of these toxins is repressed by antisense sRNAs.
In another recent study, an RNA which carries a striking
repeated sequence and is encoded upstream of the ToxN
protein of Erwinia carotovora was reported to act as an
antitoxin by binding to the ToxN protein rather than
blocking synthesis as an antisense sRNA (36).
Until now type I toxin–antitoxin gene pairs have only
been experimentally characterized in Firmicutes and
g-Proteobacteria, and our searches were based upon
what is known about these few examples. Thus, the
apparent absence of known type I toxins in the genomes
of bacteria and archaea other than Firmicutes and
g-Proteobacteria may reﬂect the limits of our methods to
detect new families or highly diverged members of known
families. As the methods for computational prediction
of type I toxin–antitoxin pairs are reﬁned and more
transcriptome information is obtained and validated
from other bacteria, the number of type I toxin–antitoxin
families is likely to expand.
Function of type I toxins
Some features of the type I toxin proteins point to paral-
lels with phage holins despite the absence of obvious
sequence similarity. Both type I toxins and holins are pre-
dicted small membrane proteins with charged or aromatic
terminal regions. Holin family proteins are extremely
diverse but all appear to retain the same mechanism of
action, namely, the formation of pores in bacterial mem-
branes. It is plausible that type I toxins function through
the same mechanism as holins (37); killing the cell by
forming pores. However, similarities between type I
toxins and other small hydrophobic proteins, such as
peptides that aﬀect ribosome stalling (38), suggest other
potential modes of action. It is also quite possible that
diﬀerent families of type I toxin proteins have unique bio-
logical activities.
The toxic phenotype of many chromosomally encoded
type I toxins has only been reported upon overproduction
from a multicopy plasmid. There is very little evidence for
toxicity when these proteins are natively expressed from
the chromosome (1). Thus, as it is unlikely the levels of
the toxin would reach amounts high enough to cause
lethality, the main function of these chromosomally
encoded proteins might not be to kill the cell (calling
into question the use of the term ‘toxin’). In addition,
although we detected an sRNA encoded antisense to
B. subtilis yhzE-2, we were unable to demonstrate that
the protein was toxic, even in its native species. This
lack of toxicity could be due to insuﬃcient protein pro-
duction, or it could suggest that the protein does not
function to kill B. subtilis.
Support for a biological function other than toxicity
comes from the apparent species speciﬁcity in the eﬀects
of type I toxins. For example, TxpA is toxic only upon
overproduction in B. subtilis and is not toxic in E. coli
[(33) and data not shown]. This observation could be
due to diﬀerences in the amounts of the proteins
overproduced by diﬀerent bacteria but might also reﬂect
the native target/function of TxpA. It has been suggested
that the function of TxpA is to maintain the skin element,
a chromosomal region excised during spore formation,
within the B. subtilis genome (33). The E. faecalis TxpA
homolog EF3263 is toxic to E. coli upon overproduction;
possibly it has evolved a separate target, that is shared
between Enterococcus and E. coli, from the B. subtilis
protein.
We suggest that the distribution and evolutionary con-
servation of the type I toxins implies a genuine function in
the bacterial cell. Despite the variation in the protein
sequences across a toxin family, there are distinct
sequence signatures that unite the families
(Supplementary Figure S1), suggestive of conserved func-
tions for the toxins. Such a proposed function does not
contradict the selﬁsh role of plasmid and phage-encoded
type I toxin–antitoxin loci. Although we still lack a clear
understanding of the role of the type I toxins, our data
demonstrates their broad distribution across bacterial
species. With the discovery of new families, and further
experimentation with identiﬁed systems, the function of
these loci will undoubtedly be revealed.
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Supplementary Data are available at NAR Online.
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